Eradication of HIV by treatment of HIV-infected/AIDS patients with vitamin D-binding protein-derived macrophage activating factor GcMAF.

被引：0
|
作者：
Yamamoto, Nobuto [1 ]
Koga, Yoshihiko [1 ]
Ueda, Masumi [1 ]
机构：
[1] Socrates Inst Therapeut Immunol, Philadelphia, PA USA
来源：
CLINICAL IMMUNOLOGY | 2006年 / 119卷
关键词：
D O I：
10.1016/j.clim.2006.04.332
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 47 条
  • [41] Prevalence of Vitamin D Deficiency and Its Related Risk Factor in a Spanish Cohort of Adult HIV-Infected Patients: Effects of Antiretroviral Therapy
    Cervero, Miguel
    Luis Agud, Jose
    Garcia-Lacalle, Concepcion
    Alcazar, Victoria
    Torres, Rafael
    Jose Jusdado, Juan
    Moreno Guillen, Santiago
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (09) : 763 - 771
  • [42] Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization
    Yamamoto, N
    Naraparaju, VR
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (03): : 237 - 244
  • [43] Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density
    Natsag, J.
    Kendall, M. A.
    Sellmeyer, D. E.
    McComsey, G. A.
    Brown, T. T.
    [J]. HIV MEDICINE, 2016, 17 (03) : 196 - 205
  • [44] Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naive HIV-infected patients
    Lambert-Niclot, S.
    Machouf, N.
    Peytavin, G.
    Soulie, C.
    Wirden, M.
    Simon, A.
    Murphy, R. L.
    Katlama, C.
    Thomas, R.
    Calvez, V.
    Marcelin, A-G
    [J]. HIV MEDICINE, 2010, 11 (10) : 666 - 669
  • [45] The toothless osteopetrotic rat has a normal vitamin D-binding protein-macrophage activating factor (DBP-MAF) cascade and chondrodysplasia resistant to treatments with colony stimulating factor-1 (CSF-1) and/or DBP-MAF
    Odgren, PR
    Popoff, SN
    Safadi, FF
    MacKay, CA
    Mason-Savas, A
    Seifert, MF
    Marks, SC
    [J]. BONE, 1999, 25 (02) : 175 - 181
  • [46] Urine Liver-Type Fatty Acid-Binding Protein and Kidney Injury Molecule-1 in HIV-Infected Patients Receiving Combined Antiretroviral Treatment Based on Tenofovir
    Jablonowska, Elzbieta
    Wojcik, Kamila
    Piekarska, Anna
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (04) : 363 - 369
  • [47] Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study
    Hikasa, Shinichi
    Shimabukuro, Shota
    Hideta, Kyoko
    Higasa, Satoshi
    Sawada, Akihiro
    Tokugawa, Tazuko
    Tanaka, Kuniyoshi
    Yanai, Mina
    Kimura, Takeshi
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2018, 29 (14) : 1424 - 1431
12345